Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus

Area of Science:

• Immunology
• Cardiology
• Mitochondrial Biology

Background:

• Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus (SLE).
• Mitochondrial dysfunction is increasingly recognized as a key factor in SLE-related CVD.
• Mechanisms include impaired oxidative phosphorylation, altered mitochondrial membrane potential, and metabolic disruptions.

Purpose of the Study:

• To review the role of mitochondria in CVD within SLE.
• To compare SLE-specific mitochondrial vulnerabilities with general CVD.
• To explore mitochondrial pathways as therapeutic targets for SLE-CVD.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of mitochondrial mechanisms in SLE-CVD.
• Comparison of SLE-CVD with non-SLE CVD.

Main Results:

• Mitochondrial dysfunction, including oxidative stress and inflammation, significantly contributes to endothelial dysfunction in SLE.
• SLE exhibits unique mitochondrial vulnerabilities compared to non-SLE CVD.
• Preclinical and clinical data support targeting mitochondrial pathways.

Conclusions:

• Mitochondrial dysfunction is a central mechanism in SLE-associated CVD.
• Targeting mitochondrial pathways holds therapeutic potential for improving cardiovascular outcomes in SLE patients.
• Further research is needed to translate these findings into clinical practice.